Datasheet | May 28, 2014

EnteriCare Enteric Softgels Datasheet

Source: Patheon Inc.

Delayed release delivery of compounds directly to the small intestine, by-passing the acidic stomach environment. This anti-reflux drug delivery platform reduces gastric irritation, increasing the likelihood of compliance. Pharmaceutical and nutritional formulations.

Key Dosage Form Characteristics

  • Easy to swallow compared to coated enteric forms
  • May reduce reflux and gastric irritation, increasing the likelihood of compliance and repeat sales
  • Delayed-release delivery dosage form
  • Dissolution occurs in the small intestine rather than in the acidic environment of the stomach
  • Suitable for delivery of acidlabile molecules
  • Patent pending technology
  • Enteric properties are built into the uncoated gelatin shell

For full access to this content, please Register or Sign In.

Access Content EnteriCare Enteric Softgels Datasheet